Influenza
Not recruitingStudy of mRNA-1010 Influenza Vaccine Compared to Standard Flu Vaccine in Adults 50 Years and Older
Germany- Participants:18–64 years · 65+ years
- Substances:Cx-037231
- Sponsor:Moderna Inc.
Rare diseases
Investigational molecules
Locations
Back to Germany16 clinical trials in Schleswig, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)
Germany
Germany
Germany
GermanyThe busiest research cities in the country
What the registry says about research in the country
Ongoing research focuses on developing new treatments for asthma, particularly investigating novel antibody therapies and inhaler formulations for patients with uncontrolled and severe cases.
Multiple trials are evaluating innovative maintenance therapies and dose-finding studies to improve patient outcomes.
Studies targeting COPD and chronic cough conditions, with investigations into new therapeutic approaches for patients with refractory symptoms.
Research aims to reduce exacerbations and improve quality of life for patients with chronic respiratory conditions.
Clinical research examining treatments for acute ischemic stroke and innovative approaches to allergic conditions.
Trials include new vaccine technologies and immunotherapy approaches for various conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.